A detailed history of Burleson & Company, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Burleson & Company, LLC holds 30,849 shares of BMY stock, worth $1.81 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
30,849
Previous 30,847 0.01%
Holding current value
$1.81 Million
Previous $2.19 Million 1.19%
% of portfolio
0.58%
Previous 0.47%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $136 - $162
2 Added 0.01%
30,849 $2.22 Million
Q3 2022

Oct 17, 2022

SELL
$0.13 - $76.84 $0 - $537
-7 Reduced 0.02%
30,847 $2.19 Million
Q2 2022

Jul 13, 2022

BUY
$72.62 - $79.98 $944 - $1,039
13 Added 0.04%
30,854 $2.38 Million
Q1 2022

Apr 25, 2022

BUY
$61.48 - $73.72 $12,480 - $14,965
203 Added 0.66%
30,841 $2.25 Million
Q4 2021

Jan 25, 2022

SELL
$53.63 - $62.52 $12,174 - $14,192
-227 Reduced 0.74%
30,638 $1.91 Million
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $118 - $138
2 Added 0.01%
30,865 $1.83 Million
Q2 2021

Jul 22, 2021

SELL
$61.91 - $67.42 $309 - $337
-5 Reduced 0.02%
30,863 $2.06 Million
Q1 2021

May 12, 2021

BUY
$59.34 - $66.74 $178 - $200
3 Added 0.01%
30,868 $1.95 Million
Q3 2020

Nov 10, 2020

BUY
$57.43 - $63.64 $1,148 - $1,272
20 Added 0.06%
30,865 $1.97 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $14,582 - $17,047
-266 Reduced 0.86%
30,845 $1.88 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $3,572 - $5,192
77 Added 0.25%
31,111 $1.9 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $22,144 - $28,885
450 Added 1.47%
31,034 $2.09 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $2,266 - $2,687
53 Added 0.17%
30,584 $1.68 Million
Q1 2019

May 09, 2019

BUY
$45.12 - $53.8 $66,191 - $78,924
1,467 Added 5.05%
30,531 $1.48 Million
Q4 2018

Feb 27, 2019

BUY
$48.76 - $63.23 $241,215 - $312,798
4,947 Added 20.51%
29,064 $1.46 Million
Q3 2018

Dec 06, 2018

BUY
$55.19 - $62.25 $4,967 - $5,602
90 Added 0.37%
24,117 $1.29 Million
Q2 2018

Jul 31, 2018

BUY
$50.53 - $62.98 $52,904 - $65,940
1,047 Added 4.56%
24,027 $1.33 Million
Q1 2018

Apr 23, 2018

BUY
$59.92 - $68.98 $2,276 - $2,621
38 Added 0.17%
22,980 $1.45 Million
Q4 2017

Mar 19, 2018

BUY
$59.94 - $65.35 $1.38 Million - $1.5 Million
22,942
22,942 $1.41 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.